Abstract
The mannose-6-phosphate/insulin-like growth factor II receptor (M6P/IGF-IIR) is a multi-functional transmembrane glycoprotein whose major function is to bind and transport M6P-bearing glycoproteins from the trans-Golgi network or the cell surface to lysosomes. The cell surface M6P/IGF-IIR also bind and internalizes the insulin-like growth factor II. The receptor gene is considered a « candidate » tumor suppressor gene. The phenotypic consequences of loss of M6P/IGF-IIR through somatic mutation are potentially very complex since M6P/IGF-IIR has a number of roles in cellular physiology. Loss of function mutations in M6P/IGF-IIR gene could contribute to multi-step carcinogenesis. In the light of the multi-functional cellular potential roles of the M6P/IGF-IIR the purpose of this review is to highlight some recent data concerning its normal functions and the potential role of its loss in tumor pathophysiology with the aim to try to clarify the possible underlying mechanisms of its involvement in tumor development.
Similar content being viewed by others
Abbreviations
- M6P/IGF-IIR:
-
mannose-6-phosphate/insulin-like growth factor II receptor
- IGF-IR:
-
insulin-like growth factor I receptor
- RA:
-
retinoic acid
- M6P:
-
mannose-6-phosphate
- IGF-I:
-
insulin-like growth factor I
- IGF-II:
-
insulin-like growth factor II
- TGF-β :
-
transforming growth factor-β
- uPAR:
-
urokinase-type plasminogen activator receptor
- LOH:
-
loss of heterozygosity
- HCC:
-
hepatocellular carcinoma
- MI:
-
microsatellite instability
- LIF:
-
leukemia inhibitory factor
References
Baserga R (1994) Oncogenes and the strategy of growth factors. Cell 79:927–930
Berthe ML, Esslimani Sahla M, Roger P, Gleizes M, Lemamy GJ, Brouillet JP, Rochefort H (2003) Mannose-6-phosphate/insulin-like growth factor-II receptor expression levels during the progression from normal human mammary tissue to invasive breast carcinomas. Eur J Cancer 39:635–642
Blanchard F, Raher S, Duplomb L, Vusio P, Pitard V, Taupin JL, Moreau JF, Hoflack B, Minvielle S, Jacques Y, Godart A (1998) The mannose-6-phosphate/insulin-like growth factor II receptor is a nanomolar affinity receptor for glycosylated human leukemia inhibitory factor. J Biol Chem 273:20886–20893
Blanchard F, Duplomb L, Raher S, Vusio P, Hoflack B, Jacques Y, Godard A (1999) Mannose 6-Phosphate/Insulin-like growth factor II receptor mediates internalization and degradation of leukemia inhibitory factor but not signal transduction. J Biol Chem 274:24685–24693
Boyer MJ, Tannock IF (1993) Lysosomes, lysosomal enzymes, and cancer. Adv Cancer Res 60:269–291
Braulke Y, Causin C, Waheed A, Junghans U, Hasilik A, Maly P, Humbel RE, von Figura K, (1988) Mannose-6 phosphate/insulin-like growth factor II receptor: distinct binding sites for mannose-6-phosphate and insulin-like growth factor II. Biochem Biophys Res Commun 150:1287–1293
Byrd JC, Devi GR, de Souza AT, Jirtle RL, Mac Donald RG (1999) Disruption of ligand binding to the insulin-like growth factor II/mannose-6-phosphate receptor by cancer-associated missense mutations. J Biol Chem 274:24408–24416
Causin C, Waheed A, Braulke T, Junghans U, Maly P, Humbel RE, von Figura K (1988) Mannose 6-phosphate/insulin-like growth factor II-binding proteins in human serum and urine. Their relation to the mannose 6-phosphate/insulin-like growth factor II receptor. Biochem J 252:795–799
Chappell SA, Walsh T, Walker RA, Shaw JA (1997) Loss of heterozygosity at chromosome 6q in preinvasive and early invasive breast carcinomas. Br J Cancer 75:1324–1329
Chen Z, Ge Y, Landman N, Kang JX (2002) Decreased expression of the mannose 6-phosphate/insulin-like growth factor-II receptor promotes growth of human breast cancer cells. BMC Cancer. 30:2–18
Cullen KJ, Yee D, Sly WS, Perdue J, Hampton B, Lippman ME, Rosen N (1990) Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res 50:48–53
Dahms NM (1996) Insulin-like growth factor II/cation-independent mannose 6-phosphate receptor and lysosomal enzyme recognition. Biochem Soc Trans 24:136–141
De Leon DD, Terry C, Asmerom Y, Nissley P (1996) Insulin-like growth factor II modulates the routing of cathepsin D in MCF-7 breast cancer cells. Endocrinology 137:1851–1859
De Souza AT, Hankins GR, Washington MK, Orton TC, Jirtle RL (1995a) M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat Genet 11:447–449
De Souza AT, Hankins GR, Washington MK, Fine RL, Orton TC, Jirtle RL (1995b) Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumors. Oncogene 10:1725–1729
Dennis PA, Rifkin DB (1991) Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. Proc Natl Acad Sci USA 88:580–584
Devi GR, De Souza AT, Byrd JC, Jirtle RL, MacDonald RG (1999) Altered ligand binding by insulin-like growth factor II/mannose-6-phosphate receptors bearing missense mutations in human cancer. Cancer Res 59:4314–4319
Faust PL, Chirgwin JM, Kornfeld S (1987) Renin, a secretory glycoprotein, acquires phosphomannosyl residues. J Cell Biol 105:1947–1955
Ghosh P, Dahms NM, Kornfeld S (2003) Mannose-6-phosphate receptors: new twists in the tale. Nat Rev Mol Cell Biol 4:202–212
Giani C, Cullen KJ, Campani D, Rasmussen A (1996) IGF-II mRNA and protein are expressed in the stroma of invasive breast cancers: an in situ hybridization and immunohistochemistry study. Breast Cancer Res Treat 41:43–50
Godar S, Horejsi V, Weidle UH, Binder BR, Hansmann C, Stockinger H (1999) M6P/IGFII-receptor complexes urokinase receptor and plasminogen for activation of transforming growth factor-beta1. Eur J Immunol 29:1004–1013
Hankins GR, De Souza AT, Bentley RC, Patel MR, Marks JR, Iglehart JD, Jirtle RL (1996) M6P/IGF2 receptor: a candidate breast tumor suppressor gene. Oncogene. 12:2003–2009
Hebert E, Herbelin C, Bougnoux P (1994) Analysis of the IGF-II receptor gene copy number in breast carcinoma. Br J Cancer 69:120–124
Hernandez L, Kozlov S, Piras G, Stewart CL (2003) Paternal and maternal genomes confer opposite effect on proliferation, cell-cycle length, senescence, and tumor formation. Proc Natl Acad Sci USA 100:13344–13349
Kang JX, Li Y, Leaf A (1997) Mannose-6-phosphate/insulin-like growth factor-II receptor is a receptor for retinoic acid. Proc Natl Acad Sci USA 94:13671–13676
Kiess W, Greenstein LA, White RM, Lee L, Rechler MM, Nissley SP (1987) Type II insulin-like growth factor receptor is present in rat serum. Proc Natl Acad Sci USA 84:7720–7724
Kiess W, Blickenstaff GD, Sklar MM, Thomas CL, Nissley SP, Sahagian GG (1988) Biochemical evidence that the type II insulin-like growth factor receptor is identical to the cation-independent mannose 6-phosphate receptor. J Biol Chem 263:9339–9344
Killian JK, Byrd JC, Jirtle JV, Munday BL, Stoskopf MK, MacDonald RG, Jirtle RL (2000) M6P/IGF2R imprinting evolution in mammals. Mol Cell 5:707–716
Kojima I, Nishimoto I, Iiri T, Ogata E, Rosenfeld R (1988) Evidence that type II insulin-like growth factor receptor is coupled to calcium gating system. Biochem Biophys Res Commun 154:9–19
Kong FM, Anscher MS, Washington MK, Killian JK, Jirtle RL (2000) M6P/IGF2R is mutated in squamous cell carcinoma of the lung. Oncogene 19:1572–1578
Korner C, Nurnberg B, Uhde M, Braulke T (1995) Mannose 6-phosphate/insulin-like growth factor II receptor fails to interact with G-proteins. Analysis of mutant cytoplasmic receptor domains. J Biol Chem 270:287–295
Kornfeld S (1992) Structure and function of the mannose 6-phosphate/insulinlike growth factor II receptors. Annu Rev Biochem 61:307–330
Lee SJ, Nathans D (1988) Proliferin secreted by cultured cells binds to mannose 6-phosphate receptors. J Biol Chem 263:3521–3527
Lee JS, Weiss J, Martin JL, Scott CD (2003) Increased expression of the mannose-6-phosphate/insulin-like growth factor-II receptor in breast cancer cells alters tumorigenic properties in vitro and in vivo. Int J Cancer 107:564–570
Leksa V, Godar S, Cebecauer M, Hilgert I, Breuss J, Weidle UH, Horejsi V, Binder BR, Stockinger H (2002) The N terminus of mannose 6-phosphate/insulin-like growth factor 2 receptor in regulation of fibrinolysis and cell migration. J Biol Chem 277:40575–40582
LeRoith D, Baserga R, Helman L, Roberts CT Jr (1995) Insulin-like growth factors and cancer. Ann Intern Med 122:54–59
Louvi A, Accili D, Efstratiadis A (1997) Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development. Dev Biol 189:33–48
MacDonald RG, Pfeffer SR, Coussens L, Tepper MA, Brocklebank CM, Mole JE, Anderson JK, Chen E, Czech MP, Ullrich A (1988) A single receptor binds both insulin-like growth factor II and mannose-6-phosphate. Science 239:1134–1137
MacDonald RG, Tepper MA, Clairmont KB, Perregaux SB, Czech MP (1989) Serum form of the rat insulin-like growth factor II/mannose 6-phosphate receptor is truncated in the carboxyl-terminal domain. J Biol Chem 264:3256–3261
Massague J (1996) TGFbeta signaling: receptors, transducers, and Mad proteins. Cell 85:947–950
Mathieu M, Rochefort H, Barenton B, Prebois C, Vignon F (1990) Interactions of cathepsin-D and insulin-like growth factor-II (IGF-II) on the IGF-II/mannose-6-phosphate receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II. Mol Endocrinol 4:1327–1335
Mills JJ, Falls JG, De Souza AT, Jirtle RL (1998) Imprinted M6p/Igf2 receptor is mutated in rat liver tumors. Oncogene 16:2797–2802
Morgan DO, Edman JC, Standring DN, Fried VA, Smith MC, Roth RA, Rutter WJ (1987) Insulin-like growth factor II receptor as a multifunctional binding protein. Nature 329:301–307
Motyka B, Korbutt G, Pinkoski MJ, Heibein JA, Caputo A, Hobman M, Barry M, Shostak I, Sawchuk T, Holmes CF, Gauldie J, Bleackley RC (2000) Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis. Cell 103:491–500
Nissley P, Kiess W, Sklar M (1993) Developmental expression of the IGF-II/mannose 6-phosphate receptor. Mol Reprod Dev 35:408–413
Nykjaer A, Christensen EI, Vorum H, Hager H, Petersen CM, Roigaard H, Min HY, Vilhardt F, Moller LB, Kornfeld S, Gliemann J (1998) Mannose 6-phosphate/insulin-like growth factor-II receptor targets the urokinase receptor to lysosomes via a novel binding interaction. J Cell Biol 141:815–828
Oates AJ, Schumaker LM, Jenkins SB, Pearce AA, DaCosta SA, Arun B, Ellis MJ (1998) The mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R), a putative breast tumor suppressor gene. Breast Cancer Res Treat 47:269–281
O’Gorman DB, Costello M, Weiss J, Firth SM, Scott CD (1999) Decreased insulin-like growth factor-II/mannose 6-phosphate receptor expression enhances tumorigenicity in JEG-3 cells. Cancer Res 59:5692–5694
O’Gorman DB, Weiss J, Hettiaratchi A, Firth SM, Scott CD (2002) Insulin-like growth factor-II/mannose 6-phosphate receptor overexpression reduces growth of choriocarcinoma cells in vitro and in vivo. Endocrinology 143:4287–4294
Oka Y, Rozek LM, Czech MP (1985) Direct demonstration of rapid insulin-like growth factor II Receptor internalization and recycling in rat adipocytes. Insulin stimulates 125I-insulin-like growth factor II degradation by modulating the IGF-II receptor recycling process. J Biol Chem 260:9435–9442
Okamoto T, Ohkuni Y, Ogata E, Nishimoto I (1991) Distinct mode of G protein activation due to single residue substitution of active IGF-II receptor peptide Arg2410-Lys2423: evidence for stimulation acceptor region other than C-terminus of Gi alpha. Biochem Biophys Res Commun 179:10–16
Ouyang H, Shiwaku HO, Hagiwara H, Miura K, Abe T, Kato Y, Ohtani H, Shiiba K, Souza RF, Meltzer SJ, Horii A (1997) The insulin-like growth factor II receptor gene is mutated in genetically unstable cancers of the endometrium, stomach, and colorectum. Cancer Res. 57:1851–1854
Paik S (1992) Expression of IGF-I and IGF-II mRNA in breast tissue. Breast Cancer Res Treat 22:31–38
Piao Z, Choi Y, Park C, Lee WJ, Park JH, Kim H (1997) Deletion of the M6P/IGF2r gene in primary hepatocellular carcinoma. Cancer Lett 120:39–43
Pierce DF Jr, Gorska AE, Chytil A, Meise KS, Page DL, Coffey RJ Jr, Moses HL (1995) Mammary tumor suppression by transforming growth factor beta 1 transgene expression. Proc Natl Acad Sci USA 92:4254–4258
Plaut K, Ikeda M, Vonderhaar BK (1993) Role of growth hormone and insulin-like growth factor-I in mammary development. Endocrinology 133:1843–1848
Reaves BJ, Row PE, Bright NA, Luzio JP, Davidson HW (2000) Loss of cation-independent mannose-6-phosphate receptor expression promotes the accumulation of lysobisphosphatidic acid in multilamellar bodies. J Cell Sci 113:4099–4108
Rogers SA, Ryan G, Hammerman MR (1991) Insulin-like growth factors I and II are produced in the metanephros and are required for growth and development in vitro. J Cell Biol 113:1447–1453
Sciacca L, Costantino A, Pandini G, Mineo R, Frasca F, Scalia P, Sbraccia P, Goldfine ID, Vigneri R, Belfiore A (1999) Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism. Oncogene 18:2471–2479
Sleat DE, Chen TL, Raska K Jr, Lobel P (1995) Increased levels of glycoproteins containing mannose 6-phosphate in human breast carcinomas. Cancer Res 55:3424–3430
Souza RF, Wang S, Thakar M, Smolinski KN, Yin J, Zou TT, Kong D, Abraham JM, Toretsky JA, Meltzer SJ (1999) Expression of the wild-type insulin-like growth factor II receptor gene suppresses growth and causes death in colorectal carcinoma cells. Oncogene 18:4063–4068
Tsujiuchi T, Sasaki Y, Tsutsumi M, Konishi Y (2003) Alterations of the M6p/Igf2 receptor gene in lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine in rats. Mol Carcinog 36:32–37
Valenzano KJ, Remmler J, Lobel P (1995) Soluble insulin-like growth factor II/mannose 6-phosphate receptor carries multiple high molecular weight forms of insulin-like growth factor II in fetal bovine serum. J Biol Chem 270:16441–16448
Vignon F, Rochefort H (1992) Interactions of pro-cathepsin D and IGF-II on the mannose-6-phosphate/IGF-II receptor. Breast Cancer Res Treat 22:47–57
Volpert O, Jackson D, Bouck N, Linzer DI (1996) The insulin-like growth factor II/mannose 6-phosphate receptor is required for proliferin-induced angiogenesis. Endocrinology 137:3871–3876
Weis-Garcia F, Massague J (1996) Complementation between kinase-defective and activation-defective TGF-beta receptors reveals a novel form of receptor cooperativity essential for signaling. EMBO J 15:276–289
Xie S, Kang JX (2002) Differential expression of the mannose 6-phosphate/ insulin-like growth factor-II receptor in human breast cancer cell lines of different invasive potential. Med Sci Monit 8:BR293–300
Xu Y, Papageorgiou A, Polychronakos C (1998) Developmental regulation of the soluble form of insulin-like growth factor-II/mannose 6-phosphate receptor in human serum and amniotic fluid. J Clin Endocrinol Metab 83:437–442
Yamada T, De Souza AT, Finkelstein S, Jirtle RL (1997) Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor receptor is an early event in liver carcinogenesis. Proc Natl Acad Sci USA 94:10351–10355
Yee D, Cullen KJ, Paik S, Perdue JF, Hampton B, Schwartz A, Lippman ME, Rosen N (1988) Insulin-like growth factor II mRNA expression in human breast cancer. Cancer Res 48:6691–6696
Zaina S, Squire S (1998) The soluble type 2 insulin-like growth (IGF-II) receptor reduces organ size by IGF-II-mediated and IGF-II-independent mechanisms. J Biol Chem 273:28610–28616
Zavras AI, Pitiphat W, Wu T, Cartsos V, Lam A, Douglass CW, Diehl SR (2003) Insulin-like growth factor II receptor gene-167 genotype increases the risk of oral squamous cell carcinoma in humans. Cancer Res 63:296–297
Acknowledgments
The author would like to thank Pr. M. Monsigny and Dr. AC Roche for critical reading of manuscript and support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hébert, E. Mannose-6-phosphate/Insulin-like Growth Factor II Receptor Expression and Tumor Development. Biosci Rep 26, 7–17 (2006). https://doi.org/10.1007/s10540-006-9002-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10540-006-9002-3